pharma · Amyotrophic Lateral Sclerosis · Pharmacokinetics · NRSN
NeuroSense Therapeutics
NeuroSense Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2017
- Employees
- 30
- Programs
- 6
- Drugs
- 6
- Patents
- 2
NeuroSense Therapeutics clinical trials
Registry index of 6 ClinicalTrials.gov studies linked to NeuroSense Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
NeuroSense Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for NeuroSense Therapeutics.